谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

First-in-human Dose-Escalation Trial of BI 764532, a Delta-Like Ligand 3 (DLL3)/CD3 IgG-like T-cell Engager in Patients (pts) with DLL3-positive (DLL3+) Small-Cell Lung Cancer (SCLC) and Neuroendocrine Carcinoma (NEC).

Martin Wermke,Enriqueta Felip,Yasutoshi Kuboki,Daniel Morgensztern,Cyrus Sayehli,Miguel F. Sanmamed,Edurne Arriola,Zohra Oum'Hamed, Eric Song,Matus Studeny,Valentina Gambardella

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用 0|浏览32
暂无评分
关键词
Small-Cell Lung Cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要